Research ArticleAdult Brain
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis
R. Kurokawa, A. Baba, M. Kurokawa, A. Capizzano, O. Hassan, T. Johnson, Y. Ota, J. Kim, A. Hagiwara, T. Moritani and A. Srinivasan
American Journal of Neuroradiology February 2022, 43 (2) 202-206; DOI: https://doi.org/10.3174/ajnr.A7406
R. Kurokawa
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
A. Baba
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
M. Kurokawa
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
A. Capizzano
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
O. Hassan
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
T. Johnson
bDepartment of Biostatistics (T.J.), University of Michigan School of Public Health, Ann Arbor, Michigan
Y. Ota
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
J. Kim
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
A. Hagiwara
cDepartment of Radiology (A.H.), Juntendo University School of Medicine, Tokyo, Japan
T. Moritani
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan
A. Srinivasan
aFrom the Division of Neuroradiology (R.K., A.B., M.K., A.C., O.H., Y.O., J.K., T.M., A.S.), Department of Radiology, University of Michigan, Ann Arbor, Michigan

References
- 1.↵
- 2.↵
- Van Meir EG,
- Hadjipanayis CG,
- Norden AD, et al
- 3.↵
- Lu-Emerson C,
- Duda DG,
- Emblem KE, et al
- 4.↵
- Chinot OL,
- Wick W,
- Mason W, et al
- 5.↵
- 6.↵
- Gilbert MR,
- Dignam JJ,
- Armstrong TS, et al
- 7.↵
- 8.↵
- Choi SH,
- Jung SC,
- Kim KW, et al
- 9.↵
- 10.↵
- 11.↵
- Ellingson BM,
- Sahebjam S,
- Kim HJ, et al
- 12.↵
- Ellingson BM,
- Gerstner ER,
- Smits M, et al
- 13.↵
- 14.↵
- 15.↵
- Pope WB,
- Kim HJ,
- Huo J, et al
- 16.↵
- 17.↵
- Park JE,
- Kim HS,
- Park SY, et al
- 18.↵
- 19.↵
- Page MJ,
- McKenzie JE,
- Bossuyt PM, et al
- 20.↵
- Whiting PF,
- Rutjes AW,
- Westwood ME, et al
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- Leu K,
- Enzmann DR,
- Woodworth DC, et al
- 25.↵
- 26.↵
- 27.↵
- Huang WY,
- Wen JB,
- Wu G, et al
- 28.↵
- Plotkin SR,
- Stemmer-Rachamimov AO,
- Barker FG, 2nd., et al
- 29.↵
- Wirsching HG,
- Roelcke U,
- Weller J, et al
- 30.↵
- Omuro A,
- Beal K,
- Gutin P, et al
- 31.↵
- Pope WB,
- Lai A,
- Mehta R, et al
- 32.↵
In this issue
American Journal of Neuroradiology
Vol. 43, Issue 2
1 Feb 2022
Advertisement
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis
R. Kurokawa, A. Baba, M. Kurokawa, A. Capizzano, O. Hassan, T. Johnson, Y. Ota, J. Kim, A. Hagiwara, T. Moritani, A. Srinivasan
American Journal of Neuroradiology Feb 2022, 43 (2) 202-206; DOI: 10.3174/ajnr.A7406
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis
R. Kurokawa, A. Baba, M. Kurokawa, A. Capizzano, O. Hassan, T. Johnson, Y. Ota, J. Kim, A. Hagiwara, T. Moritani, A. Srinivasan
American Journal of Neuroradiology Feb 2022, 43 (2) 202-206; DOI: 10.3174/ajnr.A7406
Jump to section
Related Articles
Cited By...
- Usefulness of apparent diffusion coefficient values and magnetic resonance imaging histogram analysis for identifying histological types of preoperative testicular tumors
- A non-randomized, open-label, dose-finding, first-in-human, trial of combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: transgene expression persists up to 17 months post-vector injection
- Combined Cytotoxic and Immune Therapy for Primary Adult High-Grade Glioma
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Adult Brain
Functional
Similar Articles
Advertisement